tbuckley/cabot-search huggingface dataset:
Continuous Venetoclax in Previously Untreated Patients with Chronic Lymphocytic Leukemia and TP53 Abnormalities. a Study of the Italian Campus CLL
Authors: Andrea Visentin, Francesca Mauro, Lydia Scarfò, Massimo Gentile, Lucia Farina, Gianluigi Reda, Isacco Ferrarini, Giulia Proietti, Enrico Derenzini, Francesca Cibien, Candida Vitale, Alessandro Sanna, Gioachino Catania, Monia Marchetti, Roberta Murru, Gian Matteo Rigolin, Paolo Sportoletti, Luca Laurenti, Stefano Molica, Marta Coscia, Paolo Ghia, Robin Foa, Antonio Cuneo, Livio Trentin
Journal: Blood (2022)
Evaluation of Repotrectinib's Anti-MM Effects in Combination with Bortezomib, Carfilzomib, Cyclophosphamide, and Dexamethasone <i>in Vitro</i> and <i>Ex Vivo</i>
Authors: Haiming Chen, Eric Souther, Mingjie Li, Marissa-Skye Goldwater, Stacy Behare, Ava Hekmati, Huixin Yu, Isabella Nassir, Ariella Nassir, Ning Xu, James R. Berenson
Journal: Blood (2022)
Long-Read Sequencing Resolves Complex Structural Variants and Identifies Missing Disease-Causing Variants in Unsolved Cases of Hemophilia
Authors: Danny E. Miller, Miranda Galey, Shelley N Fletcher, Kerry Lannert, Marsha M Wheeler, Renuka Kandhaya-Pillai, Junko Oshima, Barbara A. Konkle, Evan E Eichler, Jill M. Johnsen
Journal: Blood (2022)
Trial in Progress: A First-in-Human Phase 1/2 Study of Hematopoietic Stem Cell Transplantation (HCT) with VOR33 (CD33-Deleted Allograft) Followed By Treatment with Gemtuzumab Ozogamicin (GO) in Patients with CD33+ Acute Myeloid Leukemia (AML) Who Are at High-Risk of Post-HCT Relapse
Authors: Brenda W. Cooper, Hyung C. Suh, Divya Koura, Guenther Koehne, Christina Cho, Nadia M. Bambace, Léa Bernard, Nirali N. Shah, Roland B. Walter, John F. DiPersio, Sritama Nath, Melissa M. Lee-Sundlov, Ali Lacy, Darren Stanizzi, Karen Kuhn, Jennifer S. Whangbo, Christopher Slapak, Glen D. Raffel
Journal: Blood (2022)
Safety and Survival Outcomes in the Non-Interventional Post-Authorization Study of Patients Treated with Pomalidomide for Relapsed and Refractory Multiple Myeloma: A Sub-Analysis of Patients with Prior Triple Class Exposure
Authors: Karthik Ramasamy, Niels Abildgaard, Marie-Christiane Vekemans, Barbara Gamberi, Angel Ramírez Payer, Gillian Millar, Annalisa Ansaloni, Margaret Atiba-Davies, David Bernasconi, Torben Plesner, Sujith Dhanasiri
Journal: Blood (2022)
Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/ Factor VIII Concentrate in Previously Treated Patients with Von Willebrand Disease
Authors: Robert F. Sidonio, Jr., Ana Boban, Leonid Dubey, Adlette Inati, Csongor Kiss, Toshko Lissitchkov, Dzmitry Novik, Elina Peteva, Ali T. Taher, Margarita Arkadevna Timofeeva, Kateryna V. Vilchevska, Vladimir Vdovin, Sylvia Werner, Sigurd Knaub, Claudia Khayat
Journal: Blood (2022)
Next Generation BTK Inhibitor Acalabrutinib with Bendamustine-Rituximab in First Line Waldenstrom's Macroglobulinemia: The Brawm Study
Authors: Neil L Berinstein, Gail Klein, Katerina Welsh, Rebecca McClure, Nicholas Allen Forward, Mona Shafey, Anna Nikonova, David MacDonald, Diego Villa, Irwindeep Sandhu, Mohammed A Aljama, Jean-François Larouche
Journal: Blood (2022)
Anti-Leukemic Activity of STRO-002 a Novel Folate Receptor-α (FR-α)-Targeting ADC in Relapsed/Refractory CBF2AT3-GLIS2 AML
Authors: Soheil Meshinchi, Lane Miller, Stephanie Massaro, Robin Williams, Elizabeth Krieger, Melinda Pauly, Catherine Nelson, Deepa Bhojwani, Rebecca Johnson, Terzah M. Horton, Hamayun Imran, Wen-I Chang, Philip Neff, Matthew Kutny, Raul C. Ribeiro, Felipe Bautista, Terri Guinipero, Kate Murray, Alex Butte, Arturo Molina
Journal: Blood (2022)
Results from the First Phase 1 Clinical Study of the B-Cell Maturation Antigen (BCMA) Nex T Chimeric Antigen Receptor (CAR) T Cell Therapy CC-98633/BMS-986354 in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
Authors: Luciano J. Costa, Shaji K Kumar, Shebli Atrash, Michaela Liedtke, Gurbakhash Kaur, Benjamin A. Derman, P. Leif Bergsagel, Sham Mailankody, Philip L. McCarthy, Josiana Limones, Yanping Chen, Sharmila Das, Jerill Thorpe, Jonathan Cacciatore, Garnet Navarro, Ashley K Koegel, Michael R. Burgess, Kristen Hege, Shambavi Richard
Journal: Blood (2022)
PACIFICA: A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary or Secondary Myelofibrosis and Severe Thrombocytopenia
Authors: John Mascarenhas, Aaron T. Gerds, Jean-Jacques Kiladjian, Konstanze Döhner, Sarah Buckley, Jennifer A. Smith, Adam R Craig, Simran Bedi Singh, Srdan Verstovsek, Claire Harrison
Journal: Blood (2022)
Efficacy of Anti-Sars-Cov-2 mRNA Vaccines in Adults with Severe Acquired Aplastic Anemia with or without Allograft
Authors: Alice Garnier, Amandine Le Bourgeois, Thierry Guillaume, Pierre Peterlin, Maxime Jullien, Marianne Coste-Burel, Marie C Bene, Patrice Chevallier
Journal: Blood (2022)
Clinical Features of Complex Karyotype in Newly Diagnosed Acute Myeloid Leukemia
Authors: Shota Yoshida, Masahiro Onozawa, Naoki Miyashita, Hiroyuki Kimura, Shogo Takahashi, Shota Yokoyama, Toshihiro Matsukawa, Shinsuke Hirabayashi, Akio Mori, Takeshi Kondo, Daisuke Hidaka, Koichiro Minauchi, Akio Shigematsu, Junichi Hashiguchi, Tetsuyuki Igarashi, Yasutaka Kakinoki, Yutaka Tsutsumi, Hiroshi Iwasaki, Hajime Kobayashi, Yoshihito Haseyama, Katsuya Fujimoto, Toshimichi Ishihara, Hajime Sakai, Satoshi Iyama, Takanori Teshima
Journal: Blood (2022)
Matching-Adjusted Indirect Comparison (MAIC) of Lisocabtagene Maraleucel (Liso-cel) Versus Axicabtagene Ciloleucel (Axi-cel) for Second-Line (2L) Treatment of Patients (Pt) with Refractory/Early Relapsed (R/R) Large B-Cell Lymphoma (LBCL)
Authors: Jeremy S. Abramson, Manali Kamdar, Fei Fei Liu, Alessandro Crotta, Alessandro Previtali, Sven L. Klijn, Pearl Wang, Aaron Situ, Yixie Zhang, Ashley Bonner, Matthew A. Lunning
Journal: Blood (2022)
Delayed Neutrophil Engraftment in Autologous Transplant Patients with Very High CD34+ Cell Collections in a Single Apheresis
Authors: Megan Melody, Madelyn Burkart, Marcelo Villa, Fenlu Zhu, Jane N. Winter, Reem Karmali, Adam Yuh Lin, Leo I. Gordon, Kehinde Adekola, Jonathan Moreira, Seema Singhal, Jayesh Mehta
Journal: Blood (2022)
Sustained Complement C1s Inhibition with Sutimlimab in Patients with Cold Agglutinin Disease Results in Continued Efficacy during Part B of the Randomized Placebo-Controlled Phase 3 Cadenza Study (NCT03347422)
Authors: Alexander Roeth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D'Sa, Bernd Jilma, Marc Michel, Ilene C. Weitz, Masaki Yamaguchi, Jun-ichi Nishimura, Josephine M.I. Vos, Joan Cid, Michael Storek, Nancy Wong, Ronnie Yoo, Jennifer Wang, Deepthi Vagge, Marek Wardecki, Frank Shafer, Michelle Lee, Catherine M. Broome
Journal: Blood (2022)
Somatic Mutations Are Frequently Detected in CML Patients before Treatment-Free Remission (TFR) Attempt with Tyrosine Kinase Inhibitor (TKI) Discontinuation but with Uncertain Predictive Value for Tfr Failure
Authors: Maria Agustina Perusini, Katia B Pagnano, Carolina Pavlovsky, Beatriz Moiraghi, Ana Ines Varela, Michele Bianchini, Jiří Mayer, Daniela Žácková, Anežka Kvetková, Tomáš Jurček, Ivana Ježíšková, Ana Beatriz Pascoal Lopes, Gislaine B O Duarte, Carmino Antonio Souza, Jessie J.F. Medeiros, Taehyung Simon Kim, Young Seok Yoo, Kyoung Ha Kim, Hye Won Lee, Myung Hee Chang, Seong Yoon Yi, Sagi Abelson, Dennis Kim
Journal: Blood (2022)
Evolutionary History of Transformation from Chronic Lymphocytic Leukemia to Richter Syndrome
Authors: Erin Michelle Parry, Romain Guieze, Ignaty Leshchiner, Connor Johnson, Eugen Tausch, Sameer A. Parikh, Camilla K Lemvigh, Julien Broséus, Sébastien Hergalant, Connor Messer, Filippo Utro, Chaya Levovitz, Kahn Rhrissorrakrai, Liang Li, Shuqiang Li, Geoffrey G Fell, Robert A. Redd, Ziao Lin, Binyamin A. Knisbacher, Christof Schneider, Stacey M. Fernandes, Julian M. Hess, Laura Z. Rassenti, Thomas J. Kipps, Nitin Jain, William G. Wierda, Florence Cymbalista, Pierre Feugier, Neil E. Kay, Kenneth J Livak, Brian P Danysh, Chip Stewart, Donna S. Neuberg, Matthew S. Davids, Jennifer R. Brown, Laxmi Parida, Stephan Stilgenbauer, Gad Getz, Catherine J. Wu
Journal: Blood (2022)
C/EBPα Confers Dependence to Fatty Acid Biosynthetic Pathways and Vulnerability to Lipid Oxidative Stress in FLT3-Mutant Leukemia
Authors: Marie Sabatier, Rudy Birsen, Laura Lauture, Léa Goupille, Clement Larrue, Sarah Mouche, Christian Recher, Jerome Tamburini, Jean-Emmanuel Sarry
Journal: Blood (2022)
Repressive β-Catenin-Ikaros Complexes Are Essential to Prevent Clonal Evolution of Human Lymphopoiesis
Authors: Kadriye Nehir Cosgun, Wei Liu, Mark E. Robinson, David Fonseca Arce, Jennifer VanOudenhove, Alberto Bigogno, Richard Flavell, Stephanie Halene, Markus Müschen
Journal: Blood (2022)
A Phase Ib/II Study of Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in Patients with Relapsed/Refractory Follicular Lymphoma: Final Analysis and Progression-Free Survival Update
Authors: Catherine S. Diefenbach, Brad S. Kahl, Lalita Banerjee, Andrew K. McMillan, Fiona Miall, Javier Briones, Raul Cordoba, John M. Burke, Jamie Hirata, Sunil Sharma, Lisa Musick, Pau Abrisqueta Costa
Journal: Blood (2022)
Risk of Venous Thromboembolism in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplant
Authors: Hussein Awada, Adel Hajj Ali, Beth M. Faiman, Allison Winter, Sandra Mazzoni, Christy J. Samaras, Craig S. Sauter, Willem J. van Heeckeren, Robert M. Dean, Brad Pohlman, Brian T. Hill, Jason Valent, Ronald M. Sobecks, Louis S. Williams, Deepa Jagadeesh, Betty K. Hamilton, Matt Kalaycio, Faiz Anwer, Jack Khouri
Journal: Blood (2022)
Venetoclax, Cladribine Plus Low-Dose Cytarabine Achieved High Remission in Patients with Relapse/Refractory Acute Leukemia: Preliminary Results of a Phase II Study
Authors: Yanyan Li, Haixia Zhou, Chaoling Wan, Mingzhu Xu, Chongsheng Qian, Tongtong Zhang, Haiping Dai, AiNing Sun, Depei Wu, Shengli Xue
Journal: Blood (2022)
Clonal Trajectories and Therapeutic Targeting of High-Risk <i>SF3B1</i>-Mutant Myelodysplastic Syndromes
Authors: Martina Sarchi, Courtnee A Clough, Anna Gallì, Gabriele Todisco, J. Philip Creamer, Luca Malcovati, Sergei Doulatov
Journal: Blood (2022)
Integrated High-Throughput Drug Profiling and CRISPR Screening Identify Novel Pathway Vulnerabilities of Leukemic Stem Cells in Chronic Myeloid Leukemia
Authors: Shady Adnan Awad, Olli Dufva, Jay Klievink, Ella Karjalainen, Aleksandr Ianevski, Paavo Pietarinen, Daehong Kim, Swapnil Potdar, Maija Wolf, Kourosh Lotfi, Tero Aittokallio, Krister Wennerberg, Kimmo Porkka, Satu Mustjoki
Journal: Blood (2022)
Use of Hormonal Therapy Increases the Risk of Venous Thrombosis in COVID-19 Patients; Results of 1071 Patient Cohort
Authors: Corinne Marie Lavasseur, Rick Mathews, Hannah Stowe McMurry, Shira Peress, Jean M.G. Sabile, Ileisa Oleson, Thomas Kartika, Jamie Lo, Joseph J Shatzel
Journal: Blood (2022)
Intravenous and Subcutaneous Administration of RG6234, a Novel GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Biomarker Results from a Phase I Study
Authors: Iryna Dekhtiarenko, Iva Lelios, Jan Attig, Nassim Sleiman, Domenico Lazzaro, Emilie Schindler, Jan Eckmann, Pablo Umana, Wolfgang Jacob, Meike Schneider, Carmelo Carlo-Stella, Rita Mazza, Salomon Manier, Thierry Facon, Sung-Soo Yoon, Youngil Koh, Simon J Harrison, Jeremy Er, Antonio Pinto, Francesco Volzone, Giulia Perrone, Paolo Corradini, Titouan Cazaubiel, Cyrille Hulin, Cyrille Touzeau, Philippe Moreau, Enrique M. Ocio, Carmen Maria Montes Gaisan, Rakesh Popat, Sarah Leong, Fritz Offner, Paula Rodriguez Otero, Ana Alfonso-Pierola, Martin Hutchings, Caroline Hasselbalch Riley, Ann-Marie E Bröske
Journal: Blood (2022)
Development of a Robust BH3 Profiling Toolkit for Precision Medicine in Hematologic Malignancies
Authors: Valentin Jacquier, Antoine Guillemin, Sara Ovejero-Merino, Guilhem Requirand, Ouissem Karmous-Gadacha, Laure Dutrieux, Andrea Romero, Alizée Steer, Amelie Machura, Hugues De Boussac, Jerome Moreaux, Charles Herbaux
Journal: Blood (2022)
Allogeneic Stem Cell Transplant for Myelodysplastic Syndrome in the New Molecular Era of IPSS-M
Authors: Carmelo Gurnari, Nico Gagelmann, Anita Badbaran, Hussein Awada, Danai Dima, Simona Pagliuca, Maud d'Aveni, Enrico Attardi, Raffaella Cerretti, Wolschke Christine, Marie Thérèse Rubio, Jaroslaw P. Maciejewski, Nicolaus Kröger
Journal: Blood (2022)
A Phase I Trial of PI3Kαδ Inhibitor Copanlisib in Combination with Nivolumab in Patients with Richter's Transformation (RT) or Transformed Non-Hodgkin Lymphoma (tNHL)
Authors: Geoffrey Shouse, Tanya Siddiqi, Leslie L. Popplewell, Alexandra Muir, Ivana Melgar, Kirsten Orand, Brandy Gonzalez, Sandrine Puverel, Lili Wang, Adam S Kittai, Lu Chen, Matthew S. Davids, Alexey V Danilov
Journal: Blood (2022)
Serological Response after Two Doses of Sars-Cov-2 Vaccines in CML Patients - a Prospective Study of a Brazilian Center
Authors: Ana Carolina Mourão Toreli, Leonardo Fechio, Adriana Silva Santos Duarte, Audrey Basso, Gislaine B O Duarte, Samuel de Souza Medina, Guilherme Brasil Duffles Amarante, Fernando Vieira Pericole, Bruno Deltreggia Benites, Roberto Zulli, Carmino Antonio Souza, Marcelo Addas Carvalho, Katia B Pagnano
Journal: Blood (2022)
Ferric Carboxymaltose for Long-Term Correction of Iron Deficiency Anemia in the Emergency Department
Authors: Paul Bernard Lemieux, Diletta Maira, Natalia Scaramellini, Margherita Migone De Amicis, Valeria Di Stefano, Marta Ferraresi, Elena Cassinerio, Maria Domenica Domenica Cappellini, Giovanna Graziadei, Irene Motta
Journal: Blood (2022)
Exploratory Validation of a Bespoke International Patient Symptom Survey in Idiopathic Multicentric Castleman's Disease Using Psychometric Testing: Implications for Clinical Practice and Routine Data Collection
Authors: Sudipto Mukherjee, Matthew Franklin, Francis Shupo, Nicola Mason, Grace Wayi-Wayi, Natasa Zibelnik, Mileva Repasky, John Brazier
Journal: Blood (2022)
Clinical and Molecular Features of <i>FTL3</i> non Canonical and Activation Loop Mutations
Authors: Jaymeson Gordon, Christopher Haddad, Ishani Nautiyal, Yasuo Kubota, Hetty E. Carraway, Sudipto Mukherjee, Aaron T. Gerds, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Carmelo Gurnari, Valeria Visconte
Journal: Blood (2022)
Glutamate Metabolism Shapes Osteoclast Differentiation: New Potential Therapeutic Target to Block Osteoclastic Bone Resorption in Multiple Myeloma Patients
Authors: Denise Toscani, Oxana Lungu, Vincenzo Raimondi, Martina Chiu, Nicolas Thomas Iannozzi, Jessica Burroughs Garcia, Anna Benedetta Dalla Palma, Matteo Scita, Matia Bernardi, Valentina Marchica, Paola Storti, Ovidio Bussolati, Nicola Giuliani
Journal: Blood (2022)
Real-World Effectiveness and Economic Impact Associated with Chimeric Antigen Receptor T-Cell Therapy Among Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in US
Authors: Dai Chihara, Laura Liao, Joseph Tkacz, Benjamin Lewing, Anjali Franco, Karl M. Kilgore, Loretta J. Nastoupil, Lei Chen
Journal: Blood (2022)
A Phase 1 Study with the Novel B-Cell Lymphoma 2 (Bcl-2) Inhibitor Bgb-11417 As Monotherapy or in Combination with Zanubrutinib (ZANU) in Patients (Pts) with CLL/SLL: Preliminary Data
Authors: Chan Y. Cheah, Constantine S. Tam, Masa Lasica, Emma Verner, Peter J. Browett, Mary Ann Anderson, James Hilger, Yiqian Fang, David Simpson, Stephen Opat
Journal: Blood (2022)
Efficacy and Safety of Oral Ixazomib (Ixa), Intravenous (IV) Daratumumab (Dara), and IV/Oral Dexamethasone (Dex; IDd) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) and 1-3 Prior Therapies: Results of the Final Analysis of a Phase 2 Study
Authors: Sosana Delimpasi, Meletios A. Dimopoulos, Jan Straub, Argiris Symeonidis, Roman Hájek, Cyrille Touzeau, Viralkumar K. Bhanderi, Jesus Berdeja, Petr Pavlíček, Jeffrey V. Matous, Pawel J. Robak, Kaveri Suryanarayan, Miguel Villareal, Dasha Cherepanov, Jaydeep K. Srimani, Huilan Yao, Richard Labotka, Robert Z. Orlowski
Journal: Blood (2022)
CD8 Presence and Dynamics in Glofitamab-Treated Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Using the CD8-Specific PET Tracer 89Zr-Crefmirlimab Berdoxam
Authors: Martin Hutchings, Annika Loft, Wendy Osborne, George Petrides, Fritz Offner, Ciel De Vriendt, Giuseppe Gritti, Roberto Boni, William Townsend, Irfan Kayani, Ian Wilson, Yanjie Wang, Maria Jadhav, Cristina Santini, Claire Kelly, Martin Kornacker, Jean J.L. Tessier, Ann-Marie E Bröske, Angelika Lahr, Axel Boehnke, Christoph M. Griessinger
Journal: Blood (2022)
Characterization of CNVs in a Large Cohort of VWD Patients Reveals Relationship between Disrupted Regions, Clinical Variables and Disease Type
Authors: Brooke Sadler, Pamela A Christopherson, Crystal L Perry, Daniel B. Bellissimo, Sandra L Haberichter, Gabe Haller, Lilian Antunes, Veronica H Flood, Jorge Di Paola, Robert R Montgomery, The Zimmerman Program Investigators
Journal: Blood (2022)
Population Pharmacokinetics and Exposure-Response Analyses from Phase I-III Studies Support Copanlisib Dose Selection in Relapsed Indolent Non-Hodgkin Lymphoma
Authors: Jonathan Moss, Dirk Garmann, Rupert Austin, Florian Hiemeyer, Matthew J. Matasar, Pier Luigi Zinzani, Vita Beckert, Lidia Mongay Soler, Barrett H. Childs, Peter N. Morcos
Journal: Blood (2022)
Long-Term Durable FVIII Expression with Improvements in Bleeding Rates Following AAV-Mediated FVIII Gene Transfer for Hemophilia A: Multiyear Follow-up on the Phase I/II Trial of SPK-8011
Authors: Stacy E. Croteau, M. Elaine Eyster, Huyen Tran, Margaret V. Ragni, Benjamin J. Samelson-Jones, Lindsey George, Spencer Sullivan, John E.J. Rasko, Jill Moormeier, Pantep Angchaisuksiri, Jerome Teitel, Gili Kenet, Tung Wynn, Kristen Jaworski, Amy Macdougall, Savina Jaeger, Trupti Trivedi, Federico Mingozzi, Tiffany Chang, Gallia Levy
Journal: Blood (2022)
Molecular Relapse in Pediatric AML: Clinical Relapse May be Predicted By Increasingin MRD Level - Experiences from Real-World Data in Patients with Inv(16), t(8;21), t(9;11), t(10;11) or NPM1
Authors: Katharina Waack, Katharina Andernacht, Christiane Walter, Markus Schneider, Nils Von Neuhoff, Sophia Hahn, Amani Awada, Dirk Reinhardt
Journal: Blood (2022)
Long-Term Clinical Outcomes and Correlative Efficacy Analyses in Patients (Pts) with Relapsed/Refractory Follicular Lymphoma (r/r FL) Treated with Tisagenlecleucel in the Elara Trial
Authors: Martin Dreyling, Michael Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie L. Popplewell, Julio Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie Jose Kersten, Charalambos Andreadis, Peter A. Riedell, Phoebe Joy Ho, Jose A. Perez-Simon, Andy Chen, Loretta J. Nastoupil, Bastian von Tresckow, Andrés J M Ferreri, Takanori Teshima, Piers E.M. Patten, Joseph P. McGuirk, Andreas Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O'Donovan, Roberto Ramos, Aisha Masood, Catherine Thieblemont, Nathan H. Fowler, Stephen J. Schuster
Journal: Blood (2022)
A Phase II Study of Inotuzumab Ozogamicin for the Treatment of Measurable Residual Disease-Positive B-Cell Acute Lymphoblastic Leukemia
Authors: Jayastu Senapati, Nicholas Short, Yesid Alvarado, Jan A. Burger, Nitin Jain, Marina Konopleva, Farhad Ravandi, Courtney D. DiNardo, Lucia Masarova, Koji Sasaki, Philip A. Thompson, Alessandra Ferrajoli, Jovitta Jacob, Ejiroghene Mayor, Anna Milton, Christopher Loiselle, Rebecca Garris, Hagop Kantarjian, Elias Jabbour
Journal: Blood (2022)
Real Pandemic World Results of Personalized Prophylaxis of Bleeds in Polish Children and Adolescents with Severe Hemophilia a
Authors: Tomasz Urasinski, Klaudia Paczoska, Wanda Badowska, Halina Bobrowska, Lucja Dakowicz, Grzegorz Dobaczewski, Elzbieta Latos-Grazynska, Grazyna Karolczyk, Anna Klukowska, Andrzej Koltan, Magdalena Wojdalska, Pawel Laguna, Maciej Niedzwiecki, Danuta Pietrys, Julia Radon-Proskura, Monika Radwanska, Iwona Ruranska, Tomasz Szczepanski, Dariusz Wasinski, Irena Woznica-Karczmarz, Tomasz Ociepa
Journal: Blood (2022)
PAX5 Epigenetically Orchestrates CD58 Transcription and Modulates Blinatumomab Response in Acute Lymphoblastic Leukemia
Authors: Yizhen Li, Takaya Moriyama, Satoshi Yoshimura, Xuijie Zhao, Zhenhua LI, Xu Yang, Jacob A Steele, Shondra Miller, Elisabeth Paietta, Marina Konopleva, Jiyang Yu, Hiroto Inaba, Raul C Ribeiro, Ching-Hon Pui, Jun J. Yang
Journal: Blood (2022)
Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma
Authors: Monika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, Even Rustad, Eileen Boyle, Kylee H Maclachlan, Patrick Blaney, Saad Usmani, Gareth J. Morgan, Ola Landgren, Francesco Maura
Journal: Blood (2022)
No Evidence of BCMA Expression Loss or Systemic Immune Impairment after Treatment with the BCMA-Targeted Antibody-Drug Conjugate (ADC) Belantamab Mafodotin (Belamaf) in the DREAMM-1 and DREAMM-2 Trials of Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Authors: Daniel E. Lowther, E. Andres Houseman, Gang Han, Eleni Kleanthous, Dawson Knoblock, Xiangdong Zhou, Shreyan Banerjee, Sagar Patel, David Figueroa
Journal: Blood (2022)
Integrative Genomics Identifies a High-Risk Metabolic and TME Depleted Signature That Predicts Early Clinical Failure in DLBCL
Authors: Kerstin Wenzl, Matthew E Stokes, Joseph P. Novak, Sana Khan, Melissa A. Hopper, Jordan E. Krull, Abigail Dropik, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C. Chris Huang, Matthew J. Maurer, Lisa M. Rimsza, Brian K. Link, Susan L. Slager, Yan Asmann, Patrizia Mondello, Ryan D. Morin, Stephen M. Ansell, Thomas M. Habermann, Andrew L. Feldman, Rebecca L. King, Grzegorz S. Nowakowski, James R. Cerhan, Anita K. Gandhi, Anne J. Novak
Journal: Blood (2022)
Eltrombopag Combining Rituximab Versus Eltrombopag for Treatment of Adult Immune Thrombocytopenia: A Single Center, Retrospective Cohort Study
Authors: Xu Yanmei, Liu Xiaofan, Yunfei Chen, Feng Xue, Wei Liu, Rongfeng Fu, Ting Sun, Mankai Ju, Renchi Yang, Lei Zhang
Journal: Blood (2022)
Disease Characteristics and International Prognostic Scoring Systems (IPSS, IPSS-R, IPSS-M) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS) Participating in Two Randomized, Double-Blind, Placebo-Controlled Studies with Intravenous Sabatolimab Added to Hypomethylating Agents (HMA) (STIMULUS-MDS1 and MDS2)
Authors: Valeria Santini, Uwe Platzbecker, Pierre Fenaux, Aristoteles Giagounidis, Yasushi Miyazaki, Mikkael A. Sekeres, Zhijian Xiao, Guillermo Sanz, Marlies Van Hoef, Fei Ma, Sabine Hertle, Pedro Marques Ramos, Amer M. Zeidan
Journal: Blood (2022)
Prevalence of Clonal Hematopoiesis of Indeterminate Potential in Patients with Monoclonal B-Cell Lymphocytosis Compared to Untreated Chronic Lymphocytic Leukemia
Authors: Anisha V. Patel, Abirami Vijenthira, Aswin Sekar, Christopher J. Gibson, Stephen P. Martindale, Rayan Fardoun, Svitlana Tyekucheva, Stacey M. Fernandes, Binyamin A. Knisbacher, Cynthia K. Hahn, Gad Getz, Catherine J. Wu, Matthew S. Davids, Jennifer R. Brown
Journal: Blood (2022)
YTB323 (Rapcabtagene Autoleucel) Demonstrates Durable Efficacy and a Manageable Safety Profile in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Phase I Study Update
Authors: Pere Barba, Mi Kwon, Javier Briones, Ulrich Jaeger, Emmanuel Bachy, Didier Blaise, Nicolas Boissel, Koji Kato, Nirav N. Shah, Matthew Frigault, Peter A. Riedell, Leyla O. Shune, Takanori Teshima, Fabio Ciceri, David Pearson, Elena J Orlando, Lan Yi, Jaclyn Davis, Aisha Masood, Ian W. Flinn, Michael Dickinson
Journal: Blood (2022)
Updated Phase IIb Results of Venetoclax with FLAG-IDA in Relapsed or Refractory Acute Myeloid Leukemia
Authors: Sai Prasad Desikan, Marina Konopleva, Koichi Takahashi, Curtis A Lachowiez, Sanam Loghavi, Lian-Chun Xiao, Tapan M. Kadia, Naval Daver, Nicholas Short, Koji Sasaki, Gautam Borthakur, Ghayas C. Issa, Abhishek Maiti, Kelly S. Chien, Yesid Alvarado, Guillermo Montalban-Bravo, Lucia Masarova, Musa Yilmaz, Michael Andreeff, Elias Jabbour, Guillermo Garcia-Manero, Steven M. Kornblau, Farhad Ravandi, Hagop Kantarjian, Courtney D. DiNardo
Journal: Blood (2022)